Obesity

Novo Mike Doustdar 2
Pharma

Novo struggles to appease restless investors with new strategy

CEO Mike Doustdar acknowledged that the company’s leadership “have to convince” investors that “there is a bright future for Novo.”
Novo Nordisk

Wegovy helps free 40% of kids from obesity in phase 3 trial

Sep 8, 2026 11:07am
oral Wegovy Wegovy pill

Novo testing smaller doses of Wegovy pill in phase 3 study

Aug 20, 2026 8:51am
Mike Doustdar

Obesity not a winner-takes-all game, Novo CEO says: Reuters

Aug 13, 2026 11:33am
Karsten Munk Knudsen Novo Nordisk
Favicon Fierce Biotech

Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth

Aug 7, 2026 9:08am
oral Wegovy Wegovy pill

Novo CEO stands firm on guidance amid Wegovy pill sales onslaught

Aug 5, 2026 11:20am